The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapy.

Published in:

Journal of Surgical Oncology, 2024, v. 130, n. 1, p. 109, doi. 10.1002/jso.27689

By:

• Carpenter, Elizabeth L.;
• Van Decar, Spencer G.;
• McCarthy, Patrick M.;
• Valdera, Franklin A.;
• Adams, Alexandra M.;
• O'Shea, Anne E.;
• Smolinsky, Todd;
• Thomas, Katryna;
• Clifton, Guy T.;
• Newhook, Timothy E.;
• Peoples, George E.;
• Nelson, Daniel W.;
• Vreeland, Timothy J.

Publication type:

Article